HOME
HIV and AIDS
Hepatitis B
Hepatitis C
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV and AIDS Articles on:
  FDA-approved Treatments
 
Experimental Treatments
 
Top New Articles
HOME PAGE

Women and Children
Pregnancy / Breast-feeding / MTCT


Exposure to Antiretroviral Drugs during Pregnancy Does Not Impair HIV Negative Children's Mental Development - 8/22/08

Women and Men Respond Similarly to Antiretroviral Drugs and Experience Comparable Side Effects: GRACE, M05-730, CASTLE, ARTEM
- 8/19/2008


Social Stigma Felt by Pregnant HIV Positive Women in the U.S. - 8/19/2008

U.S. Government Updates HIV Treatment Guidelines for Children - 8/19/2008

ACOG Recommends Routine HIV Testing for All Women Ages 19-64, Regardless of Individual Risk Factors - 8/08/08

Extended-dose Nevirapine (Viramune) for Infants to Prevent HIV Transmission via Breastfeeding in Ethiopia, India, and Uganda - 8/01/08

Successful Early Treatment of HIV Positive Infants with 3-class HAART in Resource-limited Settings - 8/01/08

Is the Increased Incidence of Asthma in HIV Positive Children Treated with HAART Due to Immune Reconstitution? - 8/01/08

Crack Cocaine Use Predicts HIV Disease Progression and Mortality in HIV Positive Women - 7/29/08

HIV Persists in Breast Milk despite Antiretroviral Therapy - 7/22/08

Efavirenz (Sustiva) in Breast Milk and Blood Plasma of Mothers and Newborns - 7/22/08

Studies Show High Rates of Cancer-causing Human Papillomavirus Infection among HIV Positive Women in Africa - 7/15/08

HIV Positive Children and Adolescents Have Elevated Risk of Cardiovascular Disease - 7/08/08

Updated Guidelines for Prevention and Treatment of Opportunistic Infections in HIV Positive Adults, Adolescents, and Children - 7/08/08

New Tipranavir (Aptivus) Oral Solution Approved for Treatment-experienced Children and Adolescents with HIV - 7/04/08

Adding Tenofovir (Viread) plus Emtricitabine (Emtriva) to Short-course Zidovudine (Retrovir) and Single-dose Nevirapine (Viramune) Does Not Reduce the Risk of Mother-to-child HIV Transmission - 6/20/08

Extended Antiretroviral Prophylaxis Lowers Risk of Mother-to-child HIV Transmission during Breast-feeding, but Early Weaning Is Detrimental - 6/17/08

Double-boosted Protease Inhibitors Saquinavir (Invirase) and Lopinavir/ritonavir (Kaletra) Produce Significant CD4 Rise and Viral Load Decline in Treatment-experienced Children - 6/10/08

Oral Therapy Reduces Incidence of Bacterial Vaginosis and Promotes Vaginal Health in HIV Positive Women - 6/03/08

FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding - 5/30/08

FDA and Pfizer Set Specifications Allowing Nelfinavir (Viracept) to Again Be Prescribed for Children and Pregnant Women - 5/23/08

Body Fat and Blood Lipid Levels in Men and Women with HIV - 5/16/08

Antiretroviral Therapy and Other Interventions Can Nearly Eliminate Risk of Mother-to-Child HIV Transmission - 5/13/08

"Women Living Positive: It's My Life" National Summit Webcast  - 4/11/08

Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV  - 4/11/08

Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children - 4/04/08

AIDS-related Deaths in France Are More Frequent in Women than in Men since 2000
- 2/15/08

New 3TC (Epivir) Tablets Approved for Children with HIV - 2/12/08

Multicenter, Retrospective Study of Incidence and Predictors of Adverse Events Associated With Nevirapine Use in a Cohort of Pregnant and Nonpregnant Women Treated at 3 Urban HIV Clinics in the United States   - 2/10/08

Overall Mother-to-Child HIV Transmission Has Fallen Dramatically in the U.S., But Benefits Are Not Equal Across Racial/Ethnic Groups - 11/16/07

Lactic Acidosis in HAART-treated Women in Botswana, Africa - 10/16/07

"Women Living Positive" Survey Shows Communication Gap between HIV Positive Women and their Doctors - 10/12/07

Does Development of Resistance Matter in Use of Single-dose Nevirapine (Viramune) for Prevention of Mother-to-child Transmission of HIV? - 10/12/07

Safety and Efficacy of Enfuvirtide (Fuzeon) in Children with HIV - 9/11/07

Recent Announcements Regarding Treatment of HIV Infection in
Children   - 8/21/07

Labeling for FDA-approved Antiretrovirals Used in the Treatment of Infants and Children with HIV Infection   - 8/21/07

Treating Genital Herpes with Acyclovir May Reduce HIV Transmission Risk Only in Highly Adherent
Women   - 7/25/07

Treating HIV-Infected Infants Early Helps Them Live Longer   - 7/25/07

 

 

 














 

 

 

 

 

 

 

 

 

Protease Inhibitors (PIs)
Note: Most PIs are now used in combination with low-dose ritonavir (Norvir)
Agenerase
Agenerase (amprenavir)
Aptivus
Aptivus (tipranavir)
Crixivan
Crixivan (indinavir)
Invirase
Invirase (saquinavir )
Kaletra
Kaletra (lopinavir/ritonavir)
Lexiva
Lexiva (fosamprenavir)
Norvir
Norvir (ritonavir)
Prezista
Prezista (darunavir)
Reyataz
Reyataz (atazanavir)
Viracept
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Combivir
Combivir (zidovudine + lamivudine)
Epivir
Epivir (lamivudine; 3TC)
Emtriva
Emtriva (emtricitabine; FTC)
Epzicom
Epzicom (abacavir + lamivudine)
Retrovir
Retrovir (zidovudine; AZT)
Trizivir
Trizivir (abacavir + zidovudine +lamivudine)
Truvada
Truvada  (tenofovir + emtricitabine)
Videx
Videx (didanosine; ddI)
Viread
Viread (tenofovir)
Zerit
Zerit (stavudine; d4T)
Ziagen
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase  Inhibitors
(nNRTIs)
Rescriptor
Intelence (etravirine)
Rescriptor
Rescriptor (delavirdine)
Sustiva
Sustiva (efavirenz)
Viramune
Viramune (nevirapine)
Entry / Fusion Inhibitors
Fuzeon (enfuvirtide)
Selzentry/Celsentri ( maraviroc)
Fixed-dose Combinations
Atripla
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir
Combivir (zidovudine + lamivudine)
Trizivir
Trizivir (abacavir + zidovudine + lamivudine)
Truvada
Truvada (tenofovir + emtricitabine)
Integrase Inhibitors
Isentress (raltegravir)